Spychalski, Shelly v. Saul, Andrew

CourtDistrict Court, W.D. Wisconsin
DecidedMarch 18, 2021
Docket3:20-cv-00399
StatusUnknown

This text of Spychalski, Shelly v. Saul, Andrew (Spychalski, Shelly v. Saul, Andrew) is published on Counsel Stack Legal Research, covering District Court, W.D. Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Spychalski, Shelly v. Saul, Andrew, (W.D. Wis. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF WISCONSIN

SHELLY A. SPYCHALSKI,

Plaintiff, OPINION AND ORDER v. 20-cv-399-wmc ANDREW SAUL, Commissioner of Social Security,

Defendant.

Under to 42 U.S.C. § 405(g), plaintiff Shelly Spychalski seeks judicial review of a final determination that she was not disabled within the meaning of the Social Security Act. Plaintiff argues on appeal that Administrative Law Judge (“ALJ”) Jennifer Smiley (1) misidentified her onset date, (2) did not adequately consider Spychalski’s residual functional capacity (“RFC”), and (3) improperly rejected her subjective reports of mental health symptoms. For the reasons discussed below, the court will reverse and remand the ALJ’s decision, and oral argument set for March 18, 2021, is cancelled. BACKGROUND1 A. Application and Onset Date On April 22, 2016, Spychalski filed a Title II application for a period of disability and disability insurance benefits. In her initial application, Spychalski alleged an onset date of March 2, 2012. However, at the hearing before the ALJ, Spychalski expressly revised her claimed onset date to be April 22, 2016. (AR at 40.) While alleging some

1 The administrative record (“AR”) is available at dkt. #15. physical limitations, her claim of disability primarily rested on alleged mental limitations. (See AR at 43.)

B. Medical Record2 Spychalski’s medical records show that she has a history of PTSD, ADHD, depression, anxiety, and substance abuse. In particular, the records indicate that

Spychalski’s difficult personal history has contributed to her mental impairments, including emotional and physical abuse from her father, finding her fiancé dead in 2010, and her own abuse of heroin and other drugs. (See e.g. AR at 789.) On April 15, 2016, Spychalski underwent a mental health assessment at the Madison East Comprehensive Treatment Center, including a review of her history of medication for anxiety, depression, and ADHD, panic attacks around crowds, feelings of

isolation, and a lack of motivation. (AR at 343-44.) The treatment provider noted generally normal findings with respect to Spychalski’s appearance, eye contact, facial expression, affect, speech, gross motor skills, energy, attention, memory, and intellect. (AR at 345.) However, the provider rated Spychalski’s insight was as “poor” and her judgment as “easily overwhelmed.” (AR at 345.) The diagnosis also reflected posttraumatic stress

disorder, generalized anxiety disorder, major depressive disorder, and opioid use disorder, the latter in maintenance therapy with methadone. (AR at 345.) At a follow-up, behavioral health appointment in May of 2016 with Jessica Younger, a post-doctoral fellow working under supervision, Spychalski presented with anxious and

2 Because plaintiff’s appeal discusses only the ALJ’s treatment of Spychalski’s mental impairments, the court will likewise focus its discussion on medical records discussing those impairments. depressive symptoms, and she expressed a desire to establish care with a psychiatrist and therapist. (AR at 376.) Spychalski also reported anxiety, nervousness, difficulty relaxing, sleep issues, crying episodes, and a history of trauma. (AR at 377.) During this May 2016

appointment, Younger noted that Spychalski’s orientation, cognition, and appearance were all normal, but that her mood and affect was anxious. (AR at 377.) Two months later, on July 13, 2016, Melissa Gannage, MD, conducted a psychiatric diagnostic evaluation. (AR at 788.) Spychalski reported the following as her “chief complaint”: “My Adderall got taken away and my addictions counselor told me I should

see a psychiatrist.” (AR at 789.) Spychalski explained that she “absolutely requires Adderall to function,” and she had struggled with poor concentration and impulsivity since being taken off the medication. (AR at 789-90.) Spychalski also noted that she was experiencing “strong anxiety,” particularly in crowds, making it difficult for her to leave her house, and although still “relatively mild,” she had been “more depressed of late.” (AR at 790.) Despite this, Dr. Gannage observed that Spychalski’s thought process and

associations, judgment and insight, cognitive orientation, memory, and fund of knowledge were all generally normal, while her mood was “anxious” and her affect was “restricted.” (AR at 794-95.) On December 13, 2016, Spychalski established care with Walker Shapiro, MD (family medicine). (AR at 840.) At this appointment, she discussed her historical and ongoing heroin use disorder and treatment with methadone. (AR at 840.) Additionally,

Spychalski reported her ongoing panic attacks and having a hard time leaving her house, as well as having established care with a psychiatrist, taking sertraline for depression, and being prescribed clonidine PPN for her panic attacks. (AR at 840.) Dr. Shapiro observed that her speech, affect, thought content, thought process, insight, and judgment were all fair or normal. (AR at 841.) Spychalski next followed up with Dr. Shapiro on February

24, 2017, during which they discussed Spychalski’s desire to increase her dose of sertraline to help with her depression and to resume Adderall. (AR at 848-49.) Then, between May of 2017 and December of 2018, Spychalski met six times with Jeremy Peacock, M.D., who specializes in sleep disorders psychiatry. (See AR at 882-922.) Between May of 2017 and July of 2018, Spychalski consistently reported problems with

focus and mood, depression, inability to get out of bed, difficulty leaving the house, issues with talking and people, panic in groups, difficulty with motivation when off of Adderall, poor concentration, and low energy. (AR at 882-907.) Notably, in May of 2018, Dr. Peacock resumed Spychalski’s Adderall prescription with the goal of improving her overall function and attention. (AR at 907.) By July of 2018, Spychalski reported feeling “better overall,” and by December of 2018, she was reportedly “doing ok.” (AR at 913, 922.)

Nevertheless, Spychalski continued to report difficulty being out and about throughout her time with Dr. Peacock, and while he observed generally normal appearance, behavior, language/speech, thought process and associations, judgment and insight, memory, and fund of knowledge (AR at 883, 890-91, 899, 907, 914, 923), before July of 2018, he noted that her mood and affect were depressed, frustrated, or anxious (see AR at 883, 890-91, 899, 907).

C. Opinion Evidence Despite Spychalski’s longstanding treatment history, the only formal medical opinions offered in this record related to plaintiff’s mental limitations were those of two state agency doctors. On August 29, 2016, Michael Cremerius, Ph.D., opined that Spychalski would be limited to: understanding and remembering simple instruction;

performing simple, routine tasks; brief, infrequent, and superficial contact with co-workers and the public; and no fast paced tasks with strict production quotas, while still able to perform variable paced tasks, including end of day production quotas. (AR at 81.) Michael Bohnert, M.D., provided the other formal opinion on reconsideration on December 14, 2016. (AR at 95-96.) Dr. Bohnert concluded that Spychalski could: remember and

understand simple ideas; maintain concentration for two hour time periods in an eight hour day and a forty hour week; maintain social interaction around simple work tasks; and adapt to changes in her environment. (AR at 95-96.) However, Dr. Bohnert also opined that Spychalski “cannot concentrate or be out in public very long.” (AR at 96.)

D.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Richardson v. Perales
402 U.S. 389 (Supreme Court, 1971)
Eichstadt v. Astrue
534 F.3d 663 (Seventh Circuit, 2008)
Berger v. Astrue
516 F.3d 539 (Seventh Circuit, 2008)
Simila v. Astrue
573 F.3d 503 (Seventh Circuit, 2009)
Villano v. Astrue
556 F.3d 558 (Seventh Circuit, 2009)
Kip Yurt v. Carolyn Colvin
758 F.3d 850 (Seventh Circuit, 2014)
Cheryl Beardsley v. Carolyn Colvin
758 F.3d 834 (Seventh Circuit, 2014)
Paul Lambert v. Nancy Berryhill
896 F.3d 768 (Seventh Circuit, 2018)
Debara DeCamp v. Nancy Berryhill
916 F.3d 671 (Seventh Circuit, 2019)
Bettie Burmester v. Nancy Berryhill
920 F.3d 507 (Seventh Circuit, 2019)
Christopher Jozefyk v. Nancy Berryhill
923 F.3d 492 (Seventh Circuit, 2019)
Tara Crump v. Andrew M. Saul
932 F.3d 567 (Seventh Circuit, 2019)
Milliken v. Astrue
397 F. App'x 218 (Seventh Circuit, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Spychalski, Shelly v. Saul, Andrew, Counsel Stack Legal Research, https://law.counselstack.com/opinion/spychalski-shelly-v-saul-andrew-wiwd-2021.